↓ Skip to main content

Knock-Down of GPR88 in the Dorsal Striatum Alters the Response of Medium Spiny Neurons to the Loss of Dopamine Input and L-3-4-Dyhydroxyphenylalanine

Overview of attention for article published in Frontiers in Pharmacology, October 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Knock-Down of GPR88 in the Dorsal Striatum Alters the Response of Medium Spiny Neurons to the Loss of Dopamine Input and L-3-4-Dyhydroxyphenylalanine
Published in
Frontiers in Pharmacology, October 2019
DOI 10.3389/fphar.2019.01233
Pubmed ID
Authors

Manuela Ingallinesi, Benjamin Galet, Jonathan Pegon, Nicole Faucon Biguet, Anh Do Thi, Mark J Millan, Clotilde Mannoury la Cour, Rolando Meloni

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 21%
Student > Bachelor 3 16%
Researcher 2 11%
Student > Master 2 11%
Student > Doctoral Student 1 5%
Other 1 5%
Unknown 6 32%
Readers by discipline Count As %
Neuroscience 6 32%
Agricultural and Biological Sciences 4 21%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Psychology 1 5%
Chemistry 1 5%
Other 0 0%
Unknown 6 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2019.
All research outputs
#20,590,073
of 23,175,240 outputs
Outputs from Frontiers in Pharmacology
#10,386
of 16,565 outputs
Outputs of similar age
#307,141
of 361,462 outputs
Outputs of similar age from Frontiers in Pharmacology
#331
of 466 outputs
Altmetric has tracked 23,175,240 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,565 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,462 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 466 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.